Flurpiridaz F-18

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameFlurpiridaz F-18
Drug Alias NameFlurpiridazum (18F)氟[18F]吡达嗪Furpiridaz (18F)FLYRCADOFlurpiridaz F-18 +[9] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersMitochondrial complex I (NADH dehydrogenase) inhibitors
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsDiagnostic agentsIschemiaMyocardial Infarction +[6] 
Global Approved IndicationsDiagnostic agentsCoronary DiseaseMyocardial Ischemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/09/27
Country/TerritoryCanadaUnited StatesPuerto Rico +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesNuclear Imaging InstituteGe HealthcareGe Healthcare Ltd
Inactive CompaniesLantheus Medical Imaging Inc
Active IndicationsDiagnostic agentsMyocardial InfarctionCoronary Artery Disease +[5] 
Inactive IndicationsIschemia

Other Information

ATC CodeN/A
Related LinksN/A